BIIB FY 2013 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena

BIIBBiogen Inc.

$28B

FY 2013 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$6.9B+25.7% YoY

Gross Profit

$6.1B87.6% margin

Operating Income

$2.5B36.3% margin

Net Income

$1.9B26.9% margin

EPS (Diluted)

$7.81

Cash Flow

Operating Cash Flow

$2.3B

Free Cash Flow

-$1.2B

Stock-Based Comp.

$136M

Balance Sheet

Total Assets

$11.9B

Total Liabilities

$3.2B

Stockholders' Equity

$8.6B

Cash & Equivalents

$603M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6.9B	$5.5B	+25.7%
Gross Profit	$6.1B	$5.0B	+22.2%
Operating Income	$2.5B	$1.8B	+36.8%
Net Income	$1.9B	$1.4B	+34.9%